← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. CTRE
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

CTRE logoCareTrust REIT, Inc. (CTRE) P/E Ratio History

Historical price-to-earnings valuation from 2015 to 2025

Current P/E
25.1
Undervalued
5Y Avg P/E
176.9
-86% vs avg
PE Percentile
5%
Low
PEG Ratio
1.19
Fair
TTM EPS$1.23
Price$39.48
5Y PE Range20.9 - 1844.0
Earnings Yield3.98%

Loading P/E history...

CTRE Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
25.1vs176.9
-86%
Cheap vs History
vs. Real Estate
25.1vs24.3
+3%
In Line with Sector
vs. S&P 500
25.1vs25.2
-0%
In Line with Market
PEG Analysis
1.19
P/E ÷ EPS Growth
PEG 1-2 = Fair
Based on 96% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 7, 2026, CareTrust REIT, Inc. (CTRE) trades at a price-to-earnings ratio of 25.1x, with a stock price of $39.48 and trailing twelve-month earnings per share of $1.23.

The current P/E is 86% below its 5-year average of 176.9x. Over the past five years, CTRE's P/E has ranged from a low of 20.9x to a high of 1844.0x, placing the current valuation at the 5th percentile of its historical range.

Compared to the Real Estate sector median P/E of 24.3x, CTRE is roughly in line with its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.1x to 195.0x.

The PEG ratio of 1.19 (P/E divided by 96% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, CTRE trades roughly in line with the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CTRE DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

CTRE P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
SBRA logoSBRASabra Health Care REIT, Inc.
$5B32.0-+19%
LTC logoLTCLTC Properties, Inc.
$2B15.3Lowest-+24%
GMRE logoGMREGlobal Medical REIT Inc.
$94M115.3--95%
CHCT logoCHCTCommunity Healthcare Trust Incorporated
$500M226.2-+134%
OHI logoOHIOmega Healthcare Investors, Inc.
$14B23.71.02Best+25%
VTR logoVTRVentas, Inc.
$41B160.4-+184%Best
WELL logoWELLWelltower Inc.
$152B155.7--11%
DOC logoDOCHealthpeak Properties, Inc.
$14B195.0--72%
NHI logoNHINational Health Investors, Inc.
$4B24.5--4%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

CTRE Historical P/E Data (2015–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2025 Q3$34.68$1.3425.9x-76%
FY2025 Q2Mon Jun 30 2025 00:00:00 GM$30.60$1.2025.5x-76%
FY2025 Q1Mon Mar 31 2025 00:00:00 GM$28.58$0.9231.1x-71%
FY2024 Q4$27.05$0.7934.2x-68%
FY2024 Q3Mon Sep 30 2024 00:00:00 GM$30.86$0.7342.0x-61%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$25.10$0.6041.5x-61%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$24.37$0.5346.0x-57%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$22.38$0.5044.8x-58%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$20.50$0.3165.2x-39%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$19.86$0.16128.0x+19%
FY2023 Q1Fri Mar 31 2023 00:00:00 GM$19.58$0.3752.9x-51%
FY2022 Q2$18.44$0.011844.0x+1614%

Average P/E for displayed period: 107.6x

See CTRE's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is CTRE Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare CTRE vs WELL

Side-by-side business, growth, and profitability comparison vs Welltower Inc..

Start Comparison

CTRE — Frequently Asked Questions

Quick answers to the most common questions about buying CTRE stock.

Is CTRE stock overvalued or undervalued?

CTRE trades at 25.1x P/E, below its 5-year average of 176.9x. At the 5th percentile of historical range, the stock is priced at a discount to its own history.

How does CTRE's valuation compare to peers?

CareTrust REIT, Inc. P/E of 25.1x compares to sector median of 24.3x. The premium reflects expected growth above peers.

What is CTRE's PEG ratio?

CTRE PEG ratio is 1.19. Between 1-2 suggests valuation aligns with growth. Historical P/E data spans 2015-2025.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

CTRE P/E Ratio History (2015–2025)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.